Black Diamond Therapeutics Inc.
BDTX | NASDAQ
$1.95
-$0.01 (-0.51%)
At close: Sep 21, 2026, 4:00 PM ET
$1.96
+$0.01 (+0.51%)
After-hours:
Sep 21, 2026, 7:44 PM ET
Institutional Ownership
Net InflowTotal Institutions
108
Total Ownership
67.29%
Capital Flow
+$9.99M
Shares Change
+656.43K
Ownership Distribution
Institutions (67.29%)
Others (32.71%)
Institutional Sentiment
Overall: neutralEquity Sentiment & Activity
bullishNew Positions
23
Increased Positions
54
Reduced Positions
33
Closed Positions
24
New (23)
Increased (54)
Reduced (33)
Closed (24)
Options Sentiment & Activity
bearishPut/Call Ratio
1.820
Call Flow
56,200
Put Flow
102,300
Calls (35%)
Puts (65%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Point72 Asset Management LP | 0.18% -48.67% | < 0.01% | 100.99K | 203.99K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 18.46% -1.05% | 0.02% -4.76% | 10.56M -0.41% | 22.5M -12.71% | |
| Nea Management Company, LLC | 7.77% -0.64% | 0.54% -2.28% | 4.45M 0.00% | 9.48M -12.35% | |
| Acadian Asset Management LLC | 4.10% +43.15% | < 0.01% +9.14% | 2.35M +44.07% | 5M +26.31% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove BDTX